date:Mar 20, 2013
additions and can therefore be produced by genetically engineering plants.
Senior author Alan M Fogelman said that if the work in animal models applies to humans, consuming forms of genetically modified foods that contain apoA-1-related peptides could potentially help improve plaque-based diseases.